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ABSTRACT
Hepatitis B infection is an upcoming health problem in Malaysia. HB vaccine coverage of 
infants in Malaysia was implemented by the Malaysian government in 1989. However, there 
is no compulsory vaccination programme for adults for HB vaccination. Currently, they 
have to protect themselves with a self-paid HB vaccination. The determinant of willingness 
to pay for HB vaccination is important to examine in order to estimate the economic benefit 
of high-burden diseases, such as HB. This study includes a few determinants identified by 
a literature review and an added new variable as risk behaviour to determine willingness 
to pay.  
Keywords: Health Belief Model, Hepatitis B, vaccination, willingness to pay  
INTRODUCTION
Hepatitis results in an inflammation of 
the liver caused by a viral infection. The 
World Health Organisation estimated that 
240 million humans were chronically 
infected by HBV and globally, 240 million 
are chronically infected, while 650,000 
individuals die each year due to liver 
cirrhosis (World Health Organisation, 
2015). In Malaysia, an estimated one million 
nationals are chronically infected with the 
Hepatitis B virus (Khairullah & Merican, 
2004). The HB vaccine coverage of infants 
in Malaysia under the Expanded Programme 
on Immunisation (EPI) was implemented 
by the Malaysian government in 1989 
(Khairullah & Merican, 2004; Ng et al., 
2005). However, in Malaysia currently, there 
is no compulsory vaccination programme for 
adults for HB vaccination. Their willingness 
to pay for a self-paid HB vaccination and 
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the factors affecting their willingness to pay 
(WTP) are important to examine in order to 
estimate the economic benefit of vaccination 
for high-burden diseases, such as Hepatitis 
B. Since only a few studies (Hou et al., 2014; 
Pennie et al., 1991) focus on willingness to 
pay for existing vaccination, this study will 
identify the determinant for willingness to 
pay for a HB vaccination.
Rationale of the Study
Belief pertaining to safety and efficiency 
of vaccines is the most important factor 
in determining vaccine acceptance 
(Bodenheimer et al., 1986). However, 
some studies highlighted that doctor 
recommendation is important for increasing 
vaccine coverage among high r isk 
populations (Kee at al., 2007). Nevertheless, 
Larson et al. (2011) highlighted that public 
trust in vaccination always changes and 
depends on vaccine perception, vaccine risk 
experience of getting vaccines, religious or 
political circumstances and socioeconomic 
status. Sustained vaccine coverage works 
only if public confidence in vaccines and 
the public’s level of trust in vaccination 
increases (Larson et al., 2011). 
The information on willingness to pay 
for an existing vaccination is important 
in policy-making decisions as it helps in 
gathering information about diseases and 
the fiscal burden it places on individuals in 
addition to providing vaccines with cost-
controlled efficiency (Hou et al., 2014). 
Current literature does not provide an 
estimate of the benefit of vaccinations after 
a vaccine is introduced. Information on the 
acceptable levels of vaccination in the past 
is also lacking (Piso & Wild, 2009).
RESEARCH FRAMEWORK AND 
HYPOTHESIS SPECIFICATION
Socioeconomic Factors 
In general, most studies conducted include 
the socioeconomic variable as one of the 
components in determining a customer’s 
willingness to pay. Because Malaysia is a 
multiracial country, this research intends 
to test the racial significance difference. 
Several studies conducted in Malaysia show 
that the Chinese have a higher chance of 
infection compared to other races (Lopez 
et al., 1978; Tan et al., 1986, 1990). Hebert 
and his co-researchers also highlighted that 
race and ethnicity “play a small role” in 
vaccination as the rate of vaccination was 
shown to be low among at least one ethnic 
group, African-Americans (Hebert et al., 
2005). 
Basic economic models often focus 
on two determinants of willingness to pay, 
which are income and use of goods (Liebe et 
al., 2011). When consumers consider paying 
for improved health quality, their choices 
and responses are based on their disposable 
income. Therefore, income usually has a 
positive relationship to willingness to pay 
(Cawley, 2008; Do et al., 2006; Kartman 
et al., 1996; Lucas et al., 2007; Unutzer et 
al., 2003). Studies conducted in Sweden 
showed that lower-income patients preferred 
to finance their WTP via loans and have 
higher WTP for the treatment of obesity 
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compared to higher-income patients (Narbro 
& Sjostrom, 2000). For cardiovascular 
disease in Sweden, factors such as income, 
condition of pectoris status, attack rate 
and percentage in reduction in attack rates 
were positively related to willingness to 
pay (Kartman et al., 1996). Sometimes, 
willingness to pay correlates with income, 
tax burden and political persuasion for 
obesity in New York (Cawley, 2008). For 
cholera vaccine in Mozambique, private 
demands for a vaccine depended on lower 
price, higher income, increase in asset 
ownership, education and higher risk group 
(Lucas et al., 2007). In Western Washington, 
patients with higher risk and higher income 
were able to pay more for higher depression 
symptoms (Unutzer et al., 2003).
One of the studies conducted on allergy-
asthma in Denmark showed that education 
and age were barriers for willingness to 
pay, but not income. Another determinant 
of willingness to pay is gender. Gender is 
also one of the important variables in HIV 
and malaria vaccine studies (Sauerborn et 
al., 2005; Whittington et al., 2008). In India, 
the willingness to pay for HIV-positive 
treatment was lower for women compared 
to men (Gupta & Sankar, 2003). Therefore, 
it was postulated that if one had good 
socioeconomic status, one would be more 
willing to pay for HB vaccination. 
Hypothesis 1:  Socioeconomic  s ta tus 
has a positive effect on 
willingness to pay for HB 
vaccination. 
Knowledge Level 
Public goods can be expressed in the 
economic concept of value. When an 
individual uses goods to increase his/her 
wellbeing, he/she shows direct connection 
between himself/herself and the goods in 
terms of ‘use value’. Moreover, if goods do 
not have a link to an individual’s wellbeing, 
but to his/her knowledge, there is an indirect 
connection that is expressed as ‘non-use 
value’ (Liebe et al., 2011).
Knowledge  con tex t ,  source  o f 
information, HB transmission and vaccine 
existence will be tested. Results from Ma et 
al. (2006) showed that the healthcare provider 
is the main influence on the rate of HB 
immunisation. In another study conducted 
in France, the researchers suggested that 
knowledge of HB transmission among 
households was very poor and should be 
improved, especially for higher risk groups 
(Brouard et al., 2013). 
Despite the high willingness to pay 
for several non-available vaccines such as 
for dengue and HIV, this study attempts to 
investigate willingness to pay in the presence 
of a readily available Hepatitis vaccine in the 
market (Palanca, 2008; Whittington et al., 
2008). Lack of knowledge among parents 
(Smith et al., 2011; Becker et al., 1978) was 
found to be one of the factors influencing 
willingness to pay. Knowledge level among 
the targetted population highlighted that 
knowledge can influence Hepatitis B 
vaccination coverage (Bodenheimer et al., 
1986; Ma et al., 2007; Slonim et al., 2005). 
Therefore, it was hypothesised that if one 
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had a high level of knowledge of Hepatitis 
B, one would be more willing to pay for 
Hepatitis B vaccination. 
Hypothesis 2: High level of knowledge of 
Hepatitis B has a positive 
effect on willingness to pay 
for HB vaccination. 
Awareness 
Although awareness of Hepatitis B variables 
has been investigated in the Malaysian 
context, it only focussed on healthcare 
workers in general (Hesham et al., 2005; 
Lim & Rashwan, 2003; Sinnah et al., 1994; 
Yaacob & Samaranayake, 1989). Initially, a 
plasma-derived HB vaccine was not widely 
accepted by Malaysian dental practitioners 
due to the fear of side effects (Yaacob & 
Samaranayake, 1989) even though it was 
found to be safe and immunogenic by the 
Korea Green Cross Corporation (Sinnah 
et al., 1994). Even though employees 
in the medical sector were aware of the 
seriousness of this disease, not all of them 
were immunised against the HB virus 
(Hesham et al., 2005). Lim and Rashwan 
(2003) discovered that HB vaccination 
coverage was lower among the public 
(below 35%), but higher among healthcare 
workers at 65.6%. This outcome affirmed 
the findings of Hesham et al. (2005); in their 
study, 58.4% of healthcare workers took 
the complete vaccine schedule and 82.2% 
of them took at least one dose. Healthcare 
workers seem to be reluctant to complete 
a full vaccine schedule despite having a 
higher level of awareness compared to the 
general public. Nevertheless, in Nigeria, 
although healthcare workers were found 
to have substantial knowledge of Hepatitis 
B infection, there was a lack of knowledge 
of Hepatitis B vaccination (Daboer et al., 
2010).
“In the context of WTP analyses, the 
personal norm to pay for the good, the 
awareness of need with respect to providing 
the good, and the awareness of responsibility 
for paying are considered as behavioural 
determinants” (Liebe et al., 2011). Even 
though few studies have focussed on 
willingness to pay and awareness of the 
health perspective, one study conducted 
in Sweden revealed that awareness has 
positive acceptability on HPV vaccination 
(Dahlstrom et al., 2010). Therefore, it was 
surmised that if one had greater awareness 
on Hepatitis B and vaccination, one would 
be more willing to pay for HB vaccination. 
Hypothesis 3: Greater level of awareness 
on Hepatitis B has a positive 
effect on  willingness to pay 
for HB vaccination. 
Perception
Perception is described as an individual’s 
belief in his or her own ‘attributes’ and the 
‘interpretation’ of his/her own behaviour 
(Molden & Dweck, 2006). Belief has 
a relationship with socialisation and 
behaviour (Abraham & Sheeran, 2005). 
Individual belief is based on an individual’s 
characteristics, which can be observed 
through his/her behaviour and primary 
socialisation. Lewin’s ‘seminal field theory 
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of 1935’ is one of the earliest theories 
in health behaviour (Rimer, 2008). The 
theories of Kurt Lewin explain that an 
individual’s behaviour depends on the 
individual and the environment (Sansone et 
al., 2003). The Health Belief Model (HBM), 
developed by Godfrey Hochbaum, is based 
on Kurt Lewin’s theories, which explain 
that the perception of an individual is a 
very important determinant in individual 
reaction (Hochbaum et al., 1952). The study 
conducted by Hebert et al. (2005) showed 
that belief greatly influenced people to get 
vaccination. Luzar (1998) suggested that 
the attitude-behaviour relationship should 
be analysed to investigate an individual’s 
willingness to pay. 
Perceived susceptibility or risk of 
contracting disease is an important factor 
in influencing people to adopt healthier 
behaviour (Hochbaum et al., 1952). The 
similarity found in studies that have 
yielded this finding was that the targetted 
population perceived that they were not at 
risk. (Wai et al., 2005; Slonim et al., 2005; 
Rhodes & Hergenrather, 2002). In contrast, 
Vietnamese immigrants’ susceptibility 
and their perceptions of severity caused 
them to believe that they were at high 
risk of premature death from liver cancer 
if they evaded Hepatitis B screening (Ma 
et al., 2007). For breast cancer, perceived 
susceptibility was seen to have a positive 
relationship to willingness to pay (Chaliki 
et al., 1995). Another study also indicated 
that perceived susceptibility for cancer has a 
direct and indirect relationship to willingness 
to pay (Bosompra et al., 2001). Another 
study revealed that a positive and negative 
relationship exists between susceptibility 
and number of preventive dental visits 
(Chen & Land, 1986). Therefore, it was 
proposed that if one had greater perceived 
susceptibility to Hepatitis B, one would be 
more willing to pay for HB vaccination.
Hypothesis 4: Perceived susceptibility to 
Hepatitis B has a positive 
effect on willingness to pay 
for HB vaccination. 
Perceived severity or perception 
of seriousness can be different among 
individuals even if they are from the same 
demographic group (Hochbaum et al., 
1952). The rate of Hepatitis B vaccination 
increases in line with a health provider’s 
advice given to patients educating them 
about the seriousness of a disease (Ma et al., 
2006). Willingness to pay for genetic testing 
for cancer risk has a positive relationship to 
perceived severity (Bosompra et al., 2001). 
Therefore, it was hypothesised that if one 
had greater perceived severity of Hepatitis 
B, one would be more willing to pay for HB 
vaccination.
Hypothesis 5: Perce ived  sever i ty  of 
Hepatitis B has a positive 
effect on willingness to pay 
for HB vaccination. 
Perceived benefit is an individual’s 
perception or opinion of adopting new 
behaviour to reduce the chances of 
developing disease (Hochbaum et al., 1952). 
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In order to increase the number of women 
who undergo screening for breast cancer, 
women need to be aware of the benefits 
of breast cancer screening. The perception 
of current (Lucas et al., 2007) and future 
infectious diseases (Kim et al., 2008) 
was also found to influence households’ 
willingness to pay for vaccination. In 
another study, benefits of and trust in 
vaccination were prominent factors in 
child influenza vaccination (Bhat-Schelbert 
et al., 2012). Bosompra et al. found that 
willingness to pay for genetic testing for 
cancer risk had a positive relationship with 
perceived benefits (2001). Therefore, it is 
believed that if one perceived Hepatitis B 
to bring more benefits, one would be more 
willing to pay for HB vaccination.
Hypothesis 6: Perceived benefits of HB 
vaccination has a positive 
effect on willingness to pay 
for HB vaccination. 
Perceived barriers are the individual’s 
perception of obstacles he/she may face 
in adopting new behaviour (Hochbaum et 
al., 1952). Perceived barriers are one of the 
main concerns in adult immunisation in the 
USA (Johnson et al., 2008). Understanding 
immunisation among adults was found to 
be low, apart from the lack of interest in 
promoting immunisation by health providers 
(Johnson et al., 2008). However, willingness 
to pay for genetic testing for cancer risk 
has a negative relationship with perceived 
barriers (Bosompra et al., 2001). Therefore, 
it is hypothesised that if one had more 
perceived barriers to Hepatitis B, one would 
be less willing to pay for HB vaccination.
Hypothesis 7: A perceived barrier to 
Hepatitis B has a negative 
effect on willingness to pay 
for HB vaccination. 
Risk Factors 
The willingness to pay for vaccination has 
been found to be related to two effects, 
which were the ‘dead anyway effect’ and the 
‘high payment effect’ (Pratt & Zeckhauser, 
1996). The ‘dead anyway effect’ refers to 
the belief that even with vaccination, the 
disease would ultimately cause death, and 
therefore, spending money on vaccination 
was a waste of resources. The ‘high payment 
effect’ refers to the rise in marginal utility 
of income experienced by people at high 
risk of contracting a disease. Most of the 
studies related to willingness to pay and risk 
factors revealed the ‘high payment effect’. 
Public willingness to pay for genetic testing 
for cancer risk using a structural equation 
model showed a positive and direct effect 
on willingness to pay and cancer risk 
(Bosompra et al., 2001). Another study 
showed that high risk for diabetes led to 
individuals being willing to pay more for a 
diabetes risk reduction programme (Johnson 
et al., 2006). A different study conducted by 
Krupnick and his co-researcher on mortality 
risk reduction and willingness to pay by 
cancer patients showed that individuals with 
cancer and good mental health were more 
willing to pay compared to those without 
cancer (Krupnick et al., 2002). Therefore, 
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it is postulated that if one had more risk 
behaviour for Hepatitis B, one would be 
more willing to pay for HB vaccination.
Hypothesis 8: Risk behaviour for Hepatitis 
B has a positive effect on 
willingness to pay for HB 
vaccination.
Model of the Study
The model of this study was designed based 
on the study objectives and the Health Belief 
Model.
Figure 1. Conceptual model on the factors affecting willingness to pay for Hepatitis B vaccination
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The research questions are based on the research model depicted in Figure 1. Questions 
to answer in this study included:  
1. What is the level of knowledge and awareness of respondents of Hepatitis B 
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2. What is the risk behaviour of people with Hepatitis B infection and how does 
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perception of benefit, and perception of barriers on Hepatitis B vaccination, and 





















The research questions are based on the 
research model depicted in Figure 1. 
Questions to answer in this study included: 
1. What is the level of knowledge 
and awareness of respondents 
of Hepatitis B vaccination and 
how does knowledge level and 
awareness affect their willingness 
to pay?
2. What is the risk behaviour of people 
with Hepatitis B infection and how 
does the behaviour affect their 
willingness to pay?
3. What is the Malaysian perception 
o f  s e v e r i t y,  p e r c e p t i o n  o f 
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sustainability, perception of benefit, 
and perception of barriers on 
Hepatitis B vaccination, and how 
does respondents’ perception affect 
their willingness to pay?
4. What are the determinants of 
Hepatitis B vaccination among 
respondents and what are the 
perceived economic benefits?
SIGNIFICANCE OF STUDY
Firstly, awareness and knowledge level of 
Hepatitis B and Hepatitis B vaccination 
focus on a selected population i.e. blood 
donors, healthcare workers and individuals 
living in an urban area. However, this study 
focussed on awareness and knowledge level 
of the general population, including the rural 
and urban population.
Secondly, it is important to be aware of 
risk behaviour among the general population 
as this is necessary to foresee its future 
and current impact on the health system. 
However, in a Malaysian perspective, none 
of the previous studies on willingness to pay 
focussing on risk behaviour of Hepatitis B 
considered this to be an important issue. 
Nevertheless, this issue was already studied 
in the Romanian perceptive. 
Thirdly, from a health perspective, 
consumer perception is very important to 
determine consumer behaviour towards 
vaccination. This is the first study conducted 
in Malaysia to assess the respondent’s 
perception of Hepatitis B vaccination using 
the Health Belief Model.
Fourthly,  currently,  Hepatit is  B 
vaccination is available at no charge to 
Malaysian infants. Considering the nation’s 
willingness to pay for HB vaccination, 
the government can allocate available 
healthcare resources (vaccine) at cost-
controlled efficiency. 
Fifthly, since the introduction of 
the EPI programme in 1989, adults who 
were born before 1989 experienced low 
Hepatitis B immunisation rates and are 
considered to be a high-risk group because 
they were not protected by this mandate. 
At the moment, there are no policies or 
compulsory vaccination enforced on this 
highly productive group who can contribute 
immensely to economic development. 
Therefore, this study intended to examine 
their willingness to pay for HB vaccination 
and to recommend the best  pol icy 
development to reduce HB infection rates 
in Malaysia.
Lastly, at this moment, very few 
studies have been conducted to determine 
the willingness to pay for vaccination in 
Malaysia. Therefore, this research can 
be used as a reference by researchers or 
policy makers in the future to examine the 
willingness to pay for vaccination for other 
diseases.
CONCLUSION
The study offered a theoretical model based 
on existing literature and developed the 
determinant for a HB vaccination model 
based on the empirical investigation of the 
positive and negative effects of different 
factors on willingness to pay for HB 
vaccination. Although risk factors associated 
with willingness to pay were investigated, 
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there is no research that has attempted to 
examine the effect of risk behaviour on 
willingness to pay related to vaccination. 
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